These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19378793)

  • 1. [Anti-GBM glomerulonephritis and RPGN].
    Shimizu Y; Tomino Y
    Nihon Jinzo Gakkai Shi; 2009; 51(2):94-7. PubMed ID: 19378793
    [No Abstract]   [Full Text] [Related]  

  • 2. [Case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA-associated pachymeningitis].
    Yamazaki C; Arai S; Tamura Y; Suzuki Y; Nakajima H; Kojima K; Uchida S
    Nihon Jinzo Gakkai Shi; 2009; 51(4):490-5. PubMed ID: 19601559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies].
    Namba T; Hatanaka M; Takahashi A; Takeji M; Takahara K; Uzu T; Yamauchi A
    Nihon Jinzo Gakkai Shi; 2008; 50(1):64-8. PubMed ID: 18318246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Strategy of immunosuppressants usage for subjects with loss of renal function and infection control on RPGN].
    Yoshida M
    Nihon Jinzo Gakkai Shi; 2009; 51(2):114-20. PubMed ID: 19378797
    [No Abstract]   [Full Text] [Related]  

  • 5. Coexistence of anti-GBM antibodies and MPO-ANCA in a patient with systemic vasculitis and crescentic glomerulonephritis.
    Fernandes P; Lopes JA; Correia L; Gonçalves S; Jorge S
    Nefrologia; 2010; 30(6):709-10. PubMed ID: 21113229
    [No Abstract]   [Full Text] [Related]  

  • 6. Extracapillary glomerulonephritis type I with the coexistence of positive anti-GBM and p-ANCA antibodies.
    Toledo Perdomo K; Ortega Salas R; Pérez-Sáez MJ; Esquivias de Motta E; Espinosa Hernández M; López Andreu M; López Rubio F; Aljama García P
    Nefrologia; 2011; 31(1):113-5. PubMed ID: 21270926
    [No Abstract]   [Full Text] [Related]  

  • 7. [Case of anti-glomerular basement membrane antibody nephritis in a patient who was able to withdraw from dialysis and gave birth twice but underwent living renal transplantation due to progression to end-stage renal failure 15 years after onset].
    Iwamoto I; Naiki Y; Nose K; Akiyama T; Sakaguchi M; Matsuoka T; Samejima K; Hiroaki S; Funauchi M
    Nihon Jinzo Gakkai Shi; 2009; 51(8):1080-5. PubMed ID: 19999588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrillary glomerulonephritis presenting as rapidly progressive glomerulonephritis.
    Sharma P; Kuperman M; Racusen L; Geetha D
    Am J Kidney Dis; 2012 Jul; 60(1):157-9. PubMed ID: 22398109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [RPGN in children].
    Nakanishi K; Yoshikawa N
    Nihon Jinzo Gakkai Shi; 2009; 51(2):102-6. PubMed ID: 19378795
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapidly progressive glomerulonephritis: current and evolving treatment strategies.
    Little MA; Pusey CD
    J Nephrol; 2004; 17 Suppl 8():S10-9. PubMed ID: 15599880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Various types of glomerulonephritis. Rapidly progressive glomerulonephritis].
    Sakai O; Yoshida H
    Nihon Rinsho; 1988 Jun; 46(6):1279-84. PubMed ID: 3418895
    [No Abstract]   [Full Text] [Related]  

  • 12. [Simultaneous presence of antibodies against the glomerular basement membrane and anti-myeloperoxidase antibodies in 2 patients with rapidly progressive glomerulonephritis].
    Díaz Rodríguez C; Costero O; Torre A; De Alvaro F; Gil F; Picazo ML; Martínez-Ara J
    Nefrologia; 2002; 22(2):190-5. PubMed ID: 12085420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis.
    Tang Z; Zhou H; Yao X; Hu W; Leishi L
    Chin Med J (Engl); 1997 Mar; 110(3):206-9. PubMed ID: 9594342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive treatment with pulse methylprednisolone or plasma exchange is justified in rapidly progressive glomerulonephritis.
    Stevens ME; McConnell M; Bone JM
    Proc Eur Dial Transplant Assoc; 1983; 19():724-31. PubMed ID: 6878261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical guideline review: Rapidly progressive glomerulonephritis].
    Tamaki K; Okuda S
    Nihon Naika Gakkai Zasshi; 2002 May; 91(5):1570-82. PubMed ID: 12082750
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rapidly progressive glomerulonephritis (RPGN): Pathogenesis, pathophysiology, and therapy].
    Shimizu Y; Yamagata K; Koyama A
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():403-7. PubMed ID: 16523922
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
    Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
    Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of rapidly progressive glomerulonephritis].
    Hirayama K; Kobayashi M; Yamagata K; Koyama A
    Nihon Jinzo Gakkai Shi; 2009; 51(2):107-13. PubMed ID: 19378796
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-glomerular basement membrane antibodies.
    Silvariño R; Noboa O; Cervera R
    Isr Med Assoc J; 2014 Nov; 16(11):727-32. PubMed ID: 25558706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA deposits along glomerular basement membranes in rapidly progressive glomerulonephritis.
    Cai G; Chen P; Wu D; Shi S; Yin Z; Zhang X; Wei R; Chen X
    South Med J; 2008 Sep; 101(9):945-7. PubMed ID: 18708970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.